-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
Summit Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2017 to 2023.
- Summit Therapeutics Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 727M shares, a 4.14% increase year-over-year.
- Summit Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 620M shares, a 221% increase from 2022.
- Summit Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 193M shares, a 46.8% increase from 2021.
- Summit Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 132M shares, a 89.5% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)